Strontium Ranelate

雷奈酸锶

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameStrontium Ranelate
Drug Alias NameProtaxos阮内酸锶Bivalos雷尼酸锶Ossum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor agonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsOsteoporosis, Postmenopausal
Global Approved IndicationsOsteoporosis, Postmenopausal
Approved Indications in ChinaOsteoporosis, Postmenopausal
Original Approved Country/TerritoryEU
Original Approved Date2004/09/20
Country/TerritoryEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesFuren Pharmaceutical Group Co Ltd
Active IndicationsOsteoporosis, Postmenopausal
Inactive IndicationsN/A

Other Information

ATC CodeM05BX03
Related LinksWikipediaDrugBankKEGG